Experimental Treatment Directly Kills Prostate Tumor Cells While Reawakening Antitumor Immunity
A study published in Cancer Research details how engineered silica nanoparticles can destroy prostate tumor cells and transform the tumor microenvironment to be more responsive to immunotherapy. This research, led by Weill Cornell Medicine, shows promise for future clinical applications.
Why it matters
This represents a potential paradigm shift in oncology by combining direct tumor destruction with immune system activation.
Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell College of Engineering. The particles, derived from silicon dioxide, a common component of healthy foods or fossilized sedimentary structures from single-celled organisms, induced several complete remissions of aggressive tumors in mouse models, supporting the further investigation of their use in clinical trials .
Technical summary of medical research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in